Saturday 17 October 2026
Export DYAI’s income statement to Excel — free account
Dyadic International Inc.
DYAI Healthcare Biotechnology
Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS was flat, free cash flow fell 1,298.5% and total debt was flat, each against the same quarter a year earlier.
0.41
0.01
−2.38%
Follow DYAI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 2 | 2 | 2 |
+8 more TTM periods Free account |
| 522.58% | (2,826.83%) | (397.80%) | (244.15%) | ||
| (103.88%) | (92.86%) | (74.11%) | (65.38%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(301.98%) | (161.47%) | (118.61%) | (98.06%) | |
Average Days of Receivables |
126.57 | 96.71 | 132.92 | 103.83 | |
Free Cash Flow per Share |
(0.20) | (0.16) | (0.17) | (0.13) | |
Free Cash Flow |
(7.40) | (5.72) | (5.70) | (4.63) | |
| Other line items | |||||
Cash ROIC |
(101.10%) | (51.30%) | (38.50%) | (25.89%) | |
Accounts Receivable Turnover |
3.68 | 6.07 | 4.46 | 4.97 | |
Accounts Payable Turnover |
4.10 | 3.73 | 3.48 | 2.59 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
93.54 | 137.50 | 134.05 | 192.77 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
48.37% | 56.09% | 69.72% | 67.08% | |
Selling, General and Administrative Expense of Revenue |
162.38% | 155.49% | 186.44% | 178.17% | |
Share Based Compensation of Revenue |
17.05% | 22.18% | 30.10% | 30.30% | |
Interest Coverage |
(16.62) | (15.74) | (15.78) | (15.36) | |
Operating CF/Net income |
0.97 | 0.78 | 0.77 | 0.63 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.10 | 0.10 | 0.09 | 0.10 | |
Operating CF per Share |
(0.20) | (0.16) | (0.17) | (0.13) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates